Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiwon Oh

Showing results (31-40 of 291) with videos related to

Pageof 30
Sort By:
Immune Network|March 9, 2026
Advances in IL-2 Family Cytokine-Based Cancer Therapies: Overcoming Challenges Through Molecular Engineering and Delivery StrategiesHyunseo An, Jiwon Oh, Joonbeom Bae
Spinal Cord Series and Cases|June 7, 2017
Clinical pitfall: false-positive aquaporin-4 IgG leading to misdiagnosis of neuromyelitis optica spectrum disorder in patient with spinal arteriovenous fistulaSuradech Suthiphosuwan, Jiwon Oh, Aditya Bharatha
JAMA Neurology|November 10, 2025
2024 Diagnostic Criteria for Multiple Sclerosis-A Unified ApproachKarlo Toljan, Jiwon Oh, Daniel Ontaneda
Neurologic Clinics|November 22, 2017
Spinal Cord MRI in Multiple SclerosisAlexandra Muccilli, Estelle Seyman, Jiwon Oh
Journal of Neurology|February 9, 2026
Relationship status and the neurobehavioral symptoms of multiple sclerosis: a cross-sectional analysisDavid E Freedman, Jiwon Oh, Anthony Feinstein
Neurodegenerative Disease Management|July 21, 2025
A drug evaluation narrative review of cladribine as a treatment for multiple sclerosisSarah-Jane Martin, Shane Arsenault, Jiwon Oh
Multiple Sclerosis and Related Disorders|January 7, 2025
Not for everyone: Factors influencing who receives psychotherapy in people with multiple sclerosisDavid E Freedman, Jiwon Oh, Anthony Feinstein
The Journal of Neuropsychiatry and Clinical Neurosciences|January 31, 2025
Predictors of Antidepressant Use Among People With Multiple SclerosisDavid E Freedman, Jiwon Oh, Anthony Feinstein
Expert Review of Clinical Immunology|April 10, 2021
Vitamin D as disease-modifying therapy for multiple sclerosis?Matthew R Lincoln, Raphael Schneider, Jiwon Oh
Multiple Sclerosis and Related Disorders|April 10, 2026
How useful is the expanded disability status scale to neuropsychiatrists?David E Freedman, Jiwon Oh, Anthony Feinstein
Pageof 30

Showing results (31-40 of 291) with videos related to

Sort By:
Pageof 30
Immune Network|March 9, 2026
Advances in IL-2 Family Cytokine-Based Cancer Therapies: Overcoming Challenges Through Molecular Engineering and Delivery StrategiesHyunseo An, Jiwon Oh, Joonbeom Bae
Spinal Cord Series and Cases|June 7, 2017
Clinical pitfall: false-positive aquaporin-4 IgG leading to misdiagnosis of neuromyelitis optica spectrum disorder in patient with spinal arteriovenous fistulaSuradech Suthiphosuwan, Jiwon Oh, Aditya Bharatha
JAMA Neurology|November 10, 2025
2024 Diagnostic Criteria for Multiple Sclerosis-A Unified ApproachKarlo Toljan, Jiwon Oh, Daniel Ontaneda
Neurologic Clinics|November 22, 2017
Spinal Cord MRI in Multiple SclerosisAlexandra Muccilli, Estelle Seyman, Jiwon Oh
Journal of Neurology|February 9, 2026
Relationship status and the neurobehavioral symptoms of multiple sclerosis: a cross-sectional analysisDavid E Freedman, Jiwon Oh, Anthony Feinstein
Neurodegenerative Disease Management|July 21, 2025
A drug evaluation narrative review of cladribine as a treatment for multiple sclerosisSarah-Jane Martin, Shane Arsenault, Jiwon Oh
Multiple Sclerosis and Related Disorders|January 7, 2025
Not for everyone: Factors influencing who receives psychotherapy in people with multiple sclerosisDavid E Freedman, Jiwon Oh, Anthony Feinstein
The Journal of Neuropsychiatry and Clinical Neurosciences|January 31, 2025
Predictors of Antidepressant Use Among People With Multiple SclerosisDavid E Freedman, Jiwon Oh, Anthony Feinstein
Expert Review of Clinical Immunology|April 10, 2021
Vitamin D as disease-modifying therapy for multiple sclerosis?Matthew R Lincoln, Raphael Schneider, Jiwon Oh
Multiple Sclerosis and Related Disorders|April 10, 2026
How useful is the expanded disability status scale to neuropsychiatrists?David E Freedman, Jiwon Oh, Anthony Feinstein
Pageof 30